pXL001-TQM IL13 CAR Citations (2)
Originally described in: High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma.Kim GB, Aragon-Sanabria V, Randolph L, Jiang H, Reynolds JA, Webb BS, Madhankumar A, Lian X, Connor JR, Yang J, Dong C Bioact Mater. 2020 May 7;5(3):624-635. doi: 10.1016/j.bioactmat.2020.04.011. eCollection 2020 Sep. PubMed Journal
Articles Citing pXL001-TQM IL13 CAR
| Articles |
|---|
Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy.
Chang Y, Syahirah R, Wang X, Jin G, Torregrosa-Allen S, Elzey BD, Hummel SN, Wang T, Li C, Lian X, Deng Q, Broxmeyer HE, Bao X.
Cell Rep. 2022 Jul 19;40(3):111128. doi: 10.1016/j.celrep.2022.111128.
PubMed
Associated Plasmids |
Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2.
Ream MW, Randolph LN, Jiang Y, Chang Y, Bao X, Lian XL.
Stem Cell Reports. 2024 Mar 5:S2213-6711(24)00044-4. doi: 10.1016/j.stemcr.2024.02.006.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.